Sensitive molecular testing methods can demonstrate NSCLC driver mutations in malignant pleural effusion despite non-malignant cytology.
暂无分享,去创建一个
M. Christie | Daniel P Steinfort | L. Irving | A. Hsu | K. Pham | S. Bozinovski | Paula Loveland | Sevastjan Kranz | A. Dowers | L. Leas | Voula Dimitriadis | P. Loveland